Literature DB >> 26824964

Are Men at High Risk for Osteoporosis Underscreened? A Quality Improvement Project.

Samta Jain1, Bilori Bilori2, Amit Gupta3, Pete Spanos4, Mamta Singh5.   

Abstract

CONTEXT: Osteoporosis is a major cause of morbidity and mortality in both men and women. The mortality rate in men within 1 year of hip fracture is 37.5%, which is 51% higher than in women. Although clear guidelines exist for osteoporosis screening in women, these are less clear for men. The available guidelines recommend screening high-risk men; however, screening does not appear to be a standard practice.
OBJECTIVE: To increase screening rates of osteoporosis in high-risk men in our primary care clinic by 50%.
DESIGN: The screening rate of osteoporosis was determined in high-risk male veterans more than 50 years of age enrolled in the resident physician- and nurse practitioner-staffed primary care clinics at a Veterans Affairs Medical Center in Cleveland, OH. High-risk factors included prolonged use of steroids; hypogonadism; and autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus, which are known to be associated with osteoporosis. We surveyed health care professional trainees and nurses to explore their barriers to screening for osteoporosis in high-risk men. MAIN OUTCOME MEASURES: After creating awareness about the importance of this condition among the health care professionals, we analyzed whether this education had any impact on the screening rate.
RESULTS: The baseline screening rate in high-risk men was 11%. After phased surveys and awareness building, the screening rate increased to 20%.
CONCLUSION: Osteoporosis in high-risk men is under-screened. Creating more awareness about the impact of this condition among health professional trainees and nurses can lead to improved screening rates.

Entities:  

Mesh:

Year:  2016        PMID: 26824964      PMCID: PMC4732796          DOI: 10.7812/TPP/14-190

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  12 in total

1.  Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.

Authors:  E M Scott; I Gaywood; B B Scott
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Alendronate for osteoporosis in men with androgen-repleted hypogonadism.

Authors:  Ilan Shimon; Varda Eshed; Ram Doolman; Ben-Ami Sela; Avraham Karasik; Iris Vered
Journal:  Osteoporos Int       Date:  2005-03-15       Impact factor: 4.507

3.  International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions.

Authors:  E Michael Lewiecki; Catherine M Gordon; Sanford Baim; Mary B Leonard; Nicholas J Bishop; Maria-Luisa Bianchi; Heidi J Kalkwarf; Craig B Langman; Horatio Plotkin; Frank Rauch; Babette S Zemel; Neil Binkley; John P Bilezikian; David L Kendler; Didier B Hans; Stuart Silverman
Journal:  Bone       Date:  2008-08-15       Impact factor: 4.398

4.  Survival after hip fracture: short- and long-term excess mortality according to age and gender.

Authors:  L Forsén; A J Sogaard; H E Meyer; T Edna; B Kopjar
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

5.  Osteoporosis in men: an Endocrine Society clinical practice guideline.

Authors:  Nelson B Watts; Robert A Adler; John P Bilezikian; Matthew T Drake; Richard Eastell; Eric S Orwoll; Joel S Finkelstein
Journal:  J Clin Endocrinol Metab       Date:  2012-06       Impact factor: 5.958

Review 6.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

7.  Steroid-induced fractures and bone loss in patients with asthma.

Authors:  A D Adinoff; J R Hollister
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

8.  Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men.

Authors:  John T Schousboe; Brent C Taylor; Howard A Fink; Robert L Kane; Steven R Cummings; Eric S Orwoll; L Joseph Melton; Douglas C Bauer; Kristine E Ensrud
Journal:  JAMA       Date:  2007-08-08       Impact factor: 56.272

9.  The aftermath of hip fracture: discharge placement, functional status change, and mortality.

Authors:  Suzanne E Bentler; Li Liu; Maksym Obrizan; Elizabeth A Cook; Kara B Wright; John F Geweke; Elizabeth A Chrischilles; Claire E Pavlik; Robert B Wallace; Robert L Ohsfeldt; Michael P Jones; Gary E Rosenthal; Fredric D Wolinsky
Journal:  Am J Epidemiol       Date:  2009-10-04       Impact factor: 4.897

10.  Risk-adjusted mortality rates of elderly veterans with hip fractures.

Authors:  Elizabeth Bass; Dustin D French; Douglas D Bradham; Laurence Z Rubenstein
Journal:  Ann Epidemiol       Date:  2007-04-08       Impact factor: 3.797

View more
  6 in total

1.  UNDERSTANDING OSTEOPOROSIS SCREENING PRACTICES IN MEN: A NATIONWIDE PHYSICIAN SURVEY.

Authors:  Palak Choksi; Brittany L Gay; David Reyes-Gastelum; Megan R Haymart; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2020-06-23       Impact factor: 3.443

2.  Limited Osteoporosis Screening Effectiveness Due to Low Treatment Rates in a National Sample of Older Men.

Authors:  Cathleen S Colón-Emeric; Carl F Pieper; Courtney H Van Houtven; Janet M Grubber; Kenneth W Lyles; Joanne Lafleur; Robert A Adler
Journal:  Mayo Clin Proc       Date:  2018-12       Impact factor: 7.616

3.  Cultivating across "pockets of excellence": challenges to sustaining efforts to improve osteoporosis care.

Authors:  Aaron T Seaman; Melissa J A Steffen; Jennifer M Van Tiem; Shylo Wardyn; Xiomara Santana; Karla L Miller; Samantha L Solimeo
Journal:  Osteoporos Int       Date:  2021-08-19       Impact factor: 4.507

4.  Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study.

Authors:  Margaret L Gourlay; Victor S Ritter; Jason P Fine; Robert A Overman; John T Schousboe; Peggy M Cawthon; Eric S Orwoll; Tuan V Nguyen; Nancy E Lane; Steven R Cummings; Deborah M Kado; Jodi A Lapidus; Susan J Diem; Kristine E Ensrud
Journal:  Arch Osteoporos       Date:  2017-10-20       Impact factor: 2.617

5.  Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey.

Authors:  Palak Choksi; Brittany L Gay; David Reyes-Gastelum; Megan R Haymart; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2020-06-23       Impact factor: 3.443

6.  Anti-atherogenic properties of vitamin E, aspirin, and their combination.

Authors:  Sheau C Chai; Elizabeth M Foley; Bahram H Arjmandi
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.